GlassScriptPhysician profile
Dawn Kopel
NPI 1497781041
$1,363.81
in general payments reported to CMS, 2019-2025
14 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $483 · 2020: $369 · 2022: $123 · 2023: $149 · 2024: $102 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $344 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $344.15 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $322.62 | 2020-2025 | Slynd |
| Coopersurgical, INC. | $318.61 | 2019-2022 | |
| Abbvie INC. | $264.59 | 2019-2020 | |
| Boston Scientific Corporation | $101.56 | 2019 | |
| Pfizer INC. | $78.93 | 2019-2025 | |
| Millicent US INC | $71.86 | 2019-2025 | Femlyv, Intrarosa |
| Therapeuticsmd, INC. | $52.01 | 2019-2022 | |
| Lupin INC. | $41.69 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $34.50 | 2020-2024 | Gardasil, Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $16.64 | 2019 | |
| Duchesnay USA Incorporated | $15.60 | 2019 | |
| Organon LLC | $15.38 | 2022 | |
| Shield Therapeutics INC | $15.02 | 2025 | |
| Mylan Pharmaceuticals INC. | $14.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Kopel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.